FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

20911711000001107: Fosrenol 1000mg oral powder sachets (Takeda UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Jul 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1799901000001112 Fosrenol 1000mg oral powder sachets (Takeda UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1799921000001117 Fosrenol 1000mg oral powder sachets (Takeda UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Fosrenol 1000mg oral powder sachets (Takeda UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Fosrenol 1000mg oral powder sachets (Takeda UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Fosrenol 1000mg oral powder sachets (Takeda UK Ltd) Has manufactured dose form Powder false Inferred relationship Existential restriction modifier
Fosrenol 1000mg oral powder sachets (Takeda UK Ltd) Has dispensed dose form Powder true Inferred relationship Existential restriction modifier
Fosrenol 1000mg oral powder sachets (Takeda UK Ltd) Is a Lanthanum carbonate 1g oral powder sachets true Inferred relationship Existential restriction modifier
Fosrenol 1000mg oral powder sachets (Takeda UK Ltd) Has active ingredient Lanthanum carbonate true Inferred relationship Existential restriction modifier
Fosrenol 1000mg oral powder sachets (Takeda UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Fosrenol 1000mg oral powder sachets (Takeda UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Fosrenol 1000mg oral powder sachets (Takeda UK Ltd) Has specific active ingredient Lanthanum carbonate true Inferred relationship Existential restriction modifier
Fosrenol 1000mg oral powder sachets (Takeda UK Ltd) Has dispensed dose form Drug powder false Inferred relationship Existential restriction modifier
Fosrenol 1000mg oral powder sachets (Takeda UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Lanthanum true Inferred relationship Existential restriction modifier
Fosrenol 1000mg oral powder sachets (Takeda UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Fosrenol 1000mg oral powder sachets (Takeda UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Fosrenol 1000mg oral powder sachets (Takeda UK Ltd) Is a Fosrenol true Inferred relationship Existential restriction modifier
Fosrenol 1000mg oral powder sachets (Takeda UK Ltd) Has manufactured dose form Drug powder false Inferred relationship Existential restriction modifier
Fosrenol 1000mg oral powder sachets (Takeda UK Ltd) Has basis of strength substance Lanthanum true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Fosrenol 1000mg oral powder sachets (Takeda UK Ltd) 90 sachet 9 x 10 sachets Has AMP True Fosrenol 1000mg oral powder sachets (Takeda UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start